A phase II clinical evaluation of radiofrequency ablation (RFA) combined with regorafenib and toripalimab in patients with colorectal cancer with liver metastases

• Published in: Journal of clinical oncology Vol. 42; no. 16_suppl; p. 3566
• Main Authors: Ouyang, Hui, Luo, Huiyan, Gao, Fei, Mie, Man, Ren, Chao, Li, Ji-Bin, Fu, Haiyan, Huang, Jin Shan
• Format: Journal Article
• Language: English
• Published: American Society of Clinical Oncology 01.06.2024

3566Background: In several clinical studies, the combination of anti-programmed cell death protein 1 (anti-PD-1) antibodies with targeted antiangiogenic agents has demonstrated clinical benefits for patients with metastatic colorectal cancer (mCRC). However, individuals with liver metastases have sh...